Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines

Radiotherapy and Oncology

Volumn 76, Issue 2, 2005, Pages 194-199

  Troost, Esther G C ^a   Bussink, Johan ^a   Kaanders, Johannes H A M ^a   Van Eerd, Julliëtte ^a   Peters, Johannes P W ^a   Rijken, Paulus F J W ^a   Boerman, Otto C ^a   Van Der Kogel, Albert J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CAIX; Head and neck cancer; Hypoxia; Pimonidazole

Indexed keywords

CARBONATE DEHYDRATASE IX; ENZYME; HOE 33342; INDIUM 111; MONOCLONAL ANTIBODY; PIMONIDAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL CULTURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ANALYSIS; ENZYME LOCALIZATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; ANTIGENS, NEOPLASM; BENZIMIDAZOLES; CARBONIC ANHYDRASES; CELL HYPOXIA; CELL LINE, TUMOR; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NITROIMIDAZOLES;

EID: 28444489221     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.06.031     Document Type: Conference Paper

References (23)

1. N.J. Beasley, C.C. Wykoff, and P.H. Watson Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density Cancer Res 61 2001 5262 5267
2. J. Bussink, J.H. Kaanders, and A.J. van der Kogel Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother Oncol 67 2003 3 15
3. A. Chrastina, J. Zavada, and S. Parkkila Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma Int J Cancer 105 2003 873 881
4. K. Grabmaier, J.L. Vissers, and M.C. De Weijert Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250 Int J Cancer 85 2000 865 870
5. D. Hedley, M. Pintilie, and J. Woo Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas Clin Cancer Res 9 2003 5666 5674
6. J.M. Henk, K. Bishop, and S.F. Shepherd Treatment of head and neck cancer with CHART and nimorazole: phase II study Radiother Oncol 66 2003 65 70
7. D.J. Hnatowich, R.L. Childs, and D. Lanteigne The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method J Immunol Methods 65 1983 147 157
8. J.H. Kaanders, K.I. Wijffels, and H.A. Marres Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res 62 2002 7066 7074
9. C.J. Koch, S.M. Evans, and E.M. Lord Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acet amide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity Br J Cancer 72 1995 869 874
10. M.I. Koukourakis, A. Giatromanolaki, and E. Sivridis Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy Clin Cancer Res 7 2001 3399 3403
11. A. Lal, H. Peters, and B. St Croix Transcriptional response to hypoxia in human tumors J Natl Cancer Inst 93 2001 1337 1343
12. Ljungkvist ASE, Bussink J, Kaanders JHAM, et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys; in press.
13. P. Mahy, M. De Bast, and B. Gallez In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors Radiother Oncol 67 2003 53 61
14. M. Nordsmark, J. Loncaster, and C. Aquino-Parsons Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas Radiother Oncol 67 2003 35 44
15. M. Nordsmark, and J. Overgaard A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy Radiother Oncol 57 2000 39 43
16. P.L. Olive, C. Aquino-Parsons, and S.H. MacPhail Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer Cancer Res 61 2001 8924 8929
17. E. Oosterwijk, D.J. Ruiter, and P.J. Hoedemaeker Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney Int J Cancer 38 1986 489 494
18. J.A. Raleigh, D.P. Calkins-Adams, and L.H. Rinker Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker Cancer Res 58 1998 3765 3768
19. P.F. Rijken, H.J. Bernsen, and J.P. Peters Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis Int J Radiat Oncol Biol Phys 48 2000 571 582
20. C.L. Ruegg, W.T. Anderson-Berg, and M.W. Brechbiel Improved in vivo stability and tumor targeting of bismuth-labeled antibody Cancer Res 50 1990 4221 4226
21. M.G. Steffens, O.C. Boerman, and J.C. Oosterwijk-Wakka Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250 J Clin Oncol 15 1997 1529 1537
22. M.P. Velders, S.V. Litvinov, and S.O. Warnaar New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency Cancer Res 54 1994 1753 1759
23. C.C. Wykoff, N.J. Beasley, and P.H. Watson Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res 60 2000 7075 7083